Sign up to save your podcasts
Or
Share Episode 43: Spoilt for choice - the many treatments now available for AMD and DME
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 43: Spoilt for choice - the many treatments now available for AMD and DME
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes
View all episodes
By Whipsmart Media
5
11 ratings
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes
More shows like Talking Euretina
View all
Ophthalmology off the Grid by Eyetube
43 Listeners
New Retina Radio by Eyetube
17 Listeners
JAMA Ophthalmology Author Interviews
5 Listeners
The Retina Channel Podcast
11 Listeners
JAMA Medical News
88 Listeners
CRST: The Podcast
8 Listeners
Retina Synthesis
8 Listeners
Headlight in the fog: The Uveitis Podcast
21 Listeners
Experts InSight
52 Listeners
RETINA Journal Podcasts
10 Listeners
Cataract Coach with Uday Devgan MD
16 Listeners
Ophthalmology Journal
18 Listeners
ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum
0 Listeners
Mayo Clinic Ophthalmology Podcast
19 Listeners
RetinaRounds™
0 Listeners